Lenexa, TX, United States of America

Biomune Company


USPTO Granted Patents = 9


Trademarks = 7

Forward Citations = 5

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Kristi M Dorsey (6 out of 9 patents)

silverMedal Brianna Ford (5 out of 5 patents)

bronzeMedal John Knox Rosenberger (3 out of 3 patents)

4.  Motoyuki Esaki (2 out of 6 patents)

5.  Lauren Elizabeth Jensen (2 out of 3 patents)

6.  Wil Solano (2 out of 2 patents)

7.  Chris Luther (2 out of 2 patents)

8.  Sandra Cloud Rosenberger (2 out of 2 patents)

9.  Christopher Luther (2 out of 2 patents)

10.  Roger H Ruehling (1 out of 1 patent)

11.  John Konx Rosenberger (1 out of 1 patent)

12.  Sharad Devidasrao Sawarkar (0 patent)

13.  Christopher Patrick Gully (0 patent)


9 patents:

Company Overview
Biomune Company is a leading biotechnology firm specializing in the research, development, and production of innovative vaccines. With a focus on animal health, our team of dedicated scientists and experts strive to protect animals from a range of infectious diseases. We employ cutting-edge technologies and rigorous testing procedures to ensure the effectiveness and safety of our vaccines. Our mission is to improve the well-being and longevity of animals, contributing to a healthier and more sustainable world.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#1 in Lenexa, TX

#2,059 in Texas

#32,588 in US

Lenexa, TX (US)
Lenexa, TX, United States of America
Forward Citations = 5

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biomune Company. Retrieved from https://idiyas.com/company/biomune-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…